Skip to main content
. 2016 Nov 4;7(50):83294–83307. doi: 10.18632/oncotarget.13065

Table 1. Clinical characteristics of 177 patients with DLBCL.

Clinical characteristic DLBCL (NOS) Primary DLBCL of CNS or Testis
Cases Percent (%) Cases Percent (%)
Age <60 117 70.90 10 83.33
>=60 48 29.10 2 16.67
Gender Female 76 46.06 5 41.67
Male 89 53.94 7 58.33
Ann Arbor stage 1~2 78 47.27 4 33.33
3~4 87 52.73 8 66.67
B symptoms No 101 61.21 9 75.00
Yes 64 38.79 3 25.00
LDH Normal 74 44.85 9 75.00
Elevated 91 55.15 3 25.00
ECOG 0~1 123 74.55 8 66.67
>=2 42 25.45 4 33.33
Massive mass No 155 93.94 12 100.00
Yes 10 6.06 0 0.00
IPI 0~1 74 44.85 6 50.00
2~3 73 44.24 5 41.67
4~5 18 10.91 1 8.33
Extranodal involvement 0-1 118 71.52 8 66.67
>=2 47 28.48 4 33.33
Response* CR 77 46.67 5 41.67
PR 61 36.97 4 33.33
SD 6 3.63 0 0.00
PD 21 12.73 3 25.00
*

assessed after 4 cycles of chemotherapy